Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Resistance development in insects significantly threatens the important benefits obtained by insecticide usage in vector control of disease-transmitting insects. Discovery of new chemical entities with insecticidal activity is highly desired in order to develop new insecticide candidates. Here, we present the design, synthesis, and biological evaluation of phenoxyacetamide-based inhibitors of the essential enzyme acetylcholinesterase 1 (AChE1). AChE1 is a validated insecticide target to control mosquito vectors of, e.g., malaria, dengue, and Zika virus infections. The inhibitors combine a mosquito versus human AChE selectivity with a high potency also for the resistance-conferring mutation G122S; two properties that have proven challenging to combine in a single compound. Structure-activity relationship analyses and molecular dynamics simulations of inhibitor-protein complexes have provided insights that elucidate the molecular basis for these properties. We also show that the inhibitors demonstrate in vivo insecticidal activity on disease-transmitting mosquitoes. Our findings support the concept of noncovalent, selective, and resistance-breaking inhibitors of AChE1 as a promising approach for future insecticide development.

Original publication

DOI

10.1021/acs.jmedchem.8b01060

Type

Journal article

Journal

Journal of medicinal chemistry

Publication Date

12/2018

Volume

61

Pages

10545 - 10557

Addresses

Department of Chemistry , Umeå University , SE-901 82 Umeå , Sweden.

Keywords

Animals, Aedes, Acetamides, Acetylcholinesterase, Cholinesterase Inhibitors, Inhibitory Concentration 50, Protein Conformation, Drug Design, Drug Resistance, Molecular Dynamics Simulation